Impact of a care manager on the outcomes of higher risk asthmatic patients: A randomized controlled trial

Journal of Asthma

Volumn 43, Issue 3, 2006, Pages 225-229

  Schatz, Michael ^a,b   Gibbons, Carlene ^a   Nelle, Catherine ^a   Harden, Kathleen ^a   Zeiger, Robert S ^a  

^a KAISER PERMANENTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Asthma; Care management; Care manager; Inhaled corticosteroid; Population management

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; STEROID;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION; EMERGENCY CARE; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH PROGRAM; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DRUG UTILIZATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PATIENT CARE MANAGEMENT; PATIENT-CENTERED CARE; QUALITY OF LIFE; RISK; SOCIOECONOMIC FACTORS;

EID: 33745062805     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900600567049     Document Type: Article

References (35)

1. Getahun D, Demissie K, Rhoads GG. Recent trends in asthma hospitalization and mortality. J Asthma 2005; 42:373-378.
2. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001; 107:3-8.
3. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Resp Crit Care Med 1997; 156:787.
4. Grana J, Preston S, McDermott PD, Hanchak NA. The use of administrative data to risk-stratify asthmatic patients. Am J Med Qual 1997; 12:113-119.
5. Lieu TA, Quesenberry CP, Sorel, Mendoza GR, Leong AB: Computer-based models to identify high-risk children with asthma. Am J Resp Crit Care Med 1998; 157:1173-1180.
6. Yurk RA, Diette GB, Skinner EA, et al. Predicting patient-reported asthma outcomes for adults in managed care. Am J Manag Care 2004; 10:321-328.
7. Schatz M, Nakahiro R, Jones CH, et al. Asthma population management: Development and validation of a practical 3-level risk stratification scheme. Am J Manag Care 2004; 10:25-32.
8. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997; 277:887.
9. Cowie RL, Underwood MF, Revitt SG, Field SK: Predicting emergency department utilization in adults with asthma: A cohort study. J Asthma 2001; 38:179-184.
10. Shireman TI, Heaton PC, Gay WE, et al. Relationship between asthma drug therapy patterns and healthcare utilization. Ann Pharmacother 2002; 36:557-564.
11. 2-agonists can reduce asthma hospitalization. Chest 2005; 127:1242-1251.
12. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute, NIH Publication 97-4051A, May 1997.
13. Rowe BH, Bota GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department. JAMA 1999; 281:2119-2126.
14. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax 2002; 57:880-884.
15. Sin DD, Man SF. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Int Med 2002; 162:1591-1595.
16. Schatz M, Cook EF, Nakahiro R, Petitti D. Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma. J Allergy Clin Immunol 2003; 111:503-508.
17. Legorreta A, Christian-Herman J, O'Connor RD, et al. Compliance with national asthma management guidelines and specialty care. Arch Int Med 1998; 158:457-464.
18. Jatulis DE, Meng Y-Y, Elashoff RM, et al. Preventive pharmacologic therapy among asthmatics five years after publication of guidelines. Ann Allergy Asthma Immunol 1998; 81:82-88.
19. Lang DM, Sherman MS, Polansky: Guidelines and realities of asthma management: The Philadelphia story. Arch Intern Med 1997; 157:1193-1200.
20. Adams RJ, Fuhlbrigge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medications in the United States. Results of the Asthma in America national population survey. J Allergy Clin Immunol 2002; 110:58-64.
21. Asthma in America: A Landmark Survey, Executive Summary, Washington, DC, October 1998.
22. Taitel MS, Kotses H, Bernstein IL, et al. A self-management program for adult asthma. Part II: cost benefit analysis. J Allergy Clin Immunol 1995; 95:672-676.
23. Doan T, Grammer LC, Yarnold PR, et al. An intervention program to reduce the hospitalization cost of asthmatic patients requiring intubation. Ann Allergy Asthma Immunol 1996; 76:513-518.
24. Jowers JR, Schwartz AL, Tinkelman DG, Reed KE, Corsello PR, Mazzei AA, et al. Disease management program improves asthma outcomes. Am J Manag Care 2000; 6:585-592.
25. Dinelli DL, Higgins JC. Case management of asthma for family practice patients: a pilot study. Mil Med 2002; 167:231-234.
26. Delaronde S. Using case management to increase anti-inflammatory medication use among a managed care population with asthma. J Asthma 2002; 39:55-63.
27. Delaronde S, Peruccio DL, Bauer BJ. Improving asthma treatment in a managed care population. Am J Manag Care 2005; 11:361-368.
28. Mayo PH, Richman J, Harris HW. Results of a program to reduce admissions for adult asthma. Ann Int Med 1990; 112:864-871.
29. Hughes DM, McLeod M, Garner B, Goldbloom RB: Controlled trial of a home and ambulatory program for asthmatic children. Pediatrics 1991; 87:54-56.
30. Lahdensuo A, Haahtela T, Herrela J, et al. Randomized comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland. BMJ 1998; 316:1138-1139.
31. Greineder DK, Loane KC, Parks P. A randomized controlled trial of a pediatric asthma outreach program. J Allergy Clin Immunol 1999; 103:436-440.
32. Castro M, Zimmerman NA, Crocker S, Bradley J, Leven C, Schechtman KB. Asthma intervention program prevents readmissions in high healthcare users. Am J Respir Crit Care Med 2003; 168:1095-1099.
33. Juniper EF, Guyatt GH, Fernie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Resp Dis 1993; 147:832-838.
34. Schatz M, Zeiger RS, Vollmer WM, Mosen D, Apter AJ, Stibolt TB, et al. Validation of a beta agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol (in press).
35. Pinnock H, McKenzie L, Price D, Sheikh A. Cost-effectiveness of telephone or surgery asthma reviews: Economic analysis of a randomized controlled trial. Br J Gen Prac 2005; 55:119-124.